scispace - formally typeset
Open AccessJournal ArticleDOI

Recent advances in the IL-17 cytokine family

Sarah L. Gaffen
- 01 Oct 2011 - 
- Vol. 23, Iss: 5, pp 613-619
Reads0
Chats0
TLDR
A review of recent advances in the field of IL-17/IL-17 receptor family biology, with an emphasis on IL- 17A biology.
About
This article is published in Current Opinion in Immunology.The article was published on 2011-10-01 and is currently open access. It has received 258 citations till now. The article focuses on the topics: Janus kinase 1 & Common gamma chain.

read more

Citations
More filters
Journal ArticleDOI

Role of cytokines in intervertebral disc degeneration: pain and disc content.

TL;DR: An enhanced understanding of the contribution of cytokines and immune cells to these catabolic, angiogenic and nociceptive processes could provide new targets for the treatment of symptomatic disc disease.
Journal ArticleDOI

STAT3 signaling in immunity.

TL;DR: Information on the numerous and distinct biological actions of STAT3 is summarized, and recent discoveries are highlighted, with a specific focus on STAT3 function in the immune and hematopoietic systems.
Journal ArticleDOI

The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings.

TL;DR: This review focuses on the emerging biology of the IL- 17 cytokine family in psoriasis, and on the molecular and genetic information gained from animal models and human clinical studies that confirm IL-17 as a crucial proinflammatory cytokine in psoriatic lesions.
Journal ArticleDOI

TRAF molecules in cell signaling and in human diseases

TL;DR: An overview of the current knowledge of TRAFs is presented, with an emphasis on recent findings concerning TRAF molecules in signaling and in human diseases.
Journal ArticleDOI

The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis.

TL;DR: The immunologic role of interleukin (IL)-17, the major effector cytokine in the pathogenesis of psoriatic disease, is reviewed, along with the rationale for targeting the IL-17 cytokine family (IL-17A, Il-17F, and IL- 17 receptor A) in the treatment of psoriasis and psoratic arthritis.
References
More filters
Journal ArticleDOI

LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis a phase I randomized, double-blind, placebo-controlled, proof-of-concept study

TL;DR: LY2439821 added to oral DMARDs improved signs and symptoms of RA, with no strong adverse safety signal noted, and supports neutralization of IL-17 as a potential novel goal for the treatment of RA.
Journal ArticleDOI

Transcriptional regulation of Th17 cell differentiation

TL;DR: How the nuclear orphan receptor RORgammat functions to coordinate the diverse cytokine-induced signals and thus controls Th17 cell differentiation is reviewed.
Journal ArticleDOI

Th1-Th17 Cells Mediate Protective Adaptive Immunity against Staphylococcus aureus and Candida albicans Infection in Mice

TL;DR: RAls3p-N vaccination induced a Th1/Th17 response, resulting in recruitment and activation of phagocytes at sites of infection, and more effective clearance of S. aureus and C. albicans from tissues, suggesting vaccine-mediated adaptive immunity can protect against both infections by targeting microbes for destruction by innate effectors.
Journal ArticleDOI

Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa

TL;DR: Recent progress is summarized in understanding of the function of IL-17-producing cells as a bridge between innate and adaptive immunity against infectious diseases at the mucosa.
Related Papers (5)